(Q37798940)

23 August 2017

title

Contraceptive vaginal rings: a review (English)

1 reference

Contraceptive Devices, Female

23 August 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20933115

29 July 2024

author name string

Vivian Brache

1

1 reference

23 August 2017

Anibal Faundes

2

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20933115

29 July 2024

publication date

20 May 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0010782410001496?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

https://api.elsevier.com/content/article/PII:S0010782410001496?httpAccept=text/plain

29 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

29 July 2024

1 reference

23 August 2017

volume

82

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

418-427

1 reference

Family planning: the unfinished agenda

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Contraceptive Effect of Varying Dosages of Progestogen in Silastic Vaginal Rings

29 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Passage of Steroids Through Silicone Rubber

29 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

THE PHYSIOLOGIC EFFECTIVENESS OF PROGESTERONE VAGINAL SUPPOSITORIES

29 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Why consider vaginal drug administration?

29 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Progestin-only contraceptive rings

29 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate

29 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The in vivo release characteristics of a multi-compartment vaginal ring releasing 3-keto-desogestrel

29 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring

29 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Causes and consequences of oral contraceptive noncompliance.

29 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Acceptability of the Contraceptive Vaginal Ring by rural and urban population in two Latin American countries

29 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

User's perception of the contraceptive vaginal ring: a field study in Brazil and the Dominican Republic

29 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring.

29 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring

29 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability

29 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.

29 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol andd-norgestrel

29 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Pituitary and gonadal function during the use of norgestrelestradiol vaginal rings

29 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Levonorgestrel and estradiol release from an improved contraceptive vaginal ring

29 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I-Use effectiveness. An international comparative trial

29 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II-Subjective and objective measures of effects. An international comparative trial

29 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III-Menstrual patterns. An international comparative trial

29 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Lipoprotein patterns in women in Santo Domingo using a levonorgestrel/estradiol contraceptive ring

29 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiol.

29 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques

29 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol

29 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol

29 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring

29 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol

29 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring

29 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles

29 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry

29 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial

29 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.

29 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen

29 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Vaginal epithelial surface appearances in women using vaginal rings for contraception

29 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception

29 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Clinical performance and endocrine profiles of contraceptive vaginal rings releasing 3-keto-desogestrel and ethinylestradiol

29 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol

29 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings

29 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The 3-keto-desogestrel/ethinylestradiol ring: a new parenteral form of hormonal contraception

29 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

29 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

29 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

29 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. IV. Bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

29 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring

29 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Ovarian function during use of vaginal rings delivering three different doses of Nestorone

29 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Vaginal rings for contraception in lactating women

29 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate

29 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol

29 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Endocrine and clinical effects of micronized estradiol administered vaginally or orally

29 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study

29 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables

29 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.

29 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study

29 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis

29 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring

29 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women

29 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devi

29 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.

29 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial

29 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition

29 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study

29 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive

29 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.

29 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring

29 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial

29 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials.

29 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Review of the combined contraceptive vaginal ring, NuvaRing

29 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive.

29 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial

29 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

A comparison between the vaginal ring and oral contraceptives.

29 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora

29 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive

29 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.

29 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study

29 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function

29 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women

29 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

The combined contraceptive vaginal ring (NuvaRing) and endometrial histology.

29 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.

29 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol

29 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.

29 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Extended regimens of the contraceptive vaginal ring: a randomized trial

29 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Bleeding patterns of women using extended regimens of the contraceptive vaginal ring

29 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial

29 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

Extended regimens of the vaginal contraceptive ring: cycle control.

29 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.CONTRACEPTION.2010.04.012

29 July 2024

Identifiers

1 reference

23 August 2017

1 reference